4577.T Живые сигналы | Максимизируйте прибыль с Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 апр. 2024 @ 09:15):

Stats
Объем за сегодня	103 100
Средний объем	61 350.00
Рыночная капитализация	39.39B
EPS	¥0 ( 2024-04-12 )
Дата следующего отчета о доходах	( ¥0 ) 2024-07-11
Last Dividend	¥30.00 ( 2023-05-30 )
Next Dividend	¥0 ( N/A )
P/E	12.12
ATR14	¥1.004 (0.04%)

Объем Корреляция

Длинно: 0.03 (neutral)

Кратко: -0.90 (very strong negative)

Signal:(42.316) Neutral

Daito Pharmaceutical Корреляция

10 Самые положительные корреляции

10 Самые отрицательные корреляции

Вы знали?

Корреляция - это статистический показатель, описывающий связь между двумя переменными. Он изменяется от -1 до 1, где -1 указывает на идеальную отрицательную корреляцию (при увеличении одной переменной другая уменьшается), 1 указывает на идеальную положительную корреляцию (при увеличении одной переменной другая увеличивается), а 0 указывает на отсутствие корреляции (между переменными нет связи).

Корреляцию можно использовать для анализа связи между любыми двумя переменными, не только акциями. Она широко используется в таких областях, как финансы, экономика, психология и т. д.

Daito Pharmaceutical Корреляция - Валюта/Сырье

0.73
( moderate )

0.55
( weak )

-0.70
( moderate negative )

-0.51
( weak negative )

-0.07
( neutral )

0.25
( neutral )

Daito Pharmaceutical Финансовые показатели

Annual	2022
Выручка:	¥45.10B
Валовая прибыль:	¥10.33B (22.91 %)
EPS:	¥227.64

FY	2022
Выручка:	¥45.10B
Валовая прибыль:	¥10.33B (22.91 %)
EPS:	¥227.64

FY	2022
Выручка:	¥43.46B
Валовая прибыль:	¥11.46B (26.36 %)
EPS:	¥335.41

FY	2021
Выручка:	¥48.71B
Валовая прибыль:	¥10.79B (22.16 %)
EPS:	¥311.02

Financial Reports:

No articles found.

Daito Pharmaceutical Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
¥0 (N/A)	¥30.00 (N/A)	¥0 (N/A)	¥30.00 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)

Daito Pharmaceutical Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 3.80 - Decrease likely (24.05%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	¥4.55	2010-05-27
Last Dividend	¥30.00	2023-05-30
Next Dividend	¥0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	24	--
Total Paid Out	¥396.45	--
Avg. Dividend % Per Year	0.00%	--
Score	3.49	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	3.80
Div. Directional Score	7.50	--

Next Divdend (Est)
(2024-07-08)

¥0 Estimate 3.54 %

Dividend Stability

0.28 Very Poor

Dividend Score

3.49

Pay Frequency

Semi-Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for JPX

Symbol	Title	Last dividend	Frequency	Yearly Dividend
6638.T	Ex Dividend Junior	2023-09-28	Annually	0.00%
5965.T	Ex Dividend Junior	2023-12-28	Annually	0.00%
4662.T	Ex Dividend Junior	2023-09-28	Annually	0.00%
3902.T	Ex Dividend Junior	2023-12-28	Annually	0.00%
3134.T	Ex Dividend Junior	2024-04-26	Annually	0.00%
2004.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
8999.T	Ex Dividend Junior	2024-03-28	Annually	0.00%
8550.T	Ex Dividend Junior	2023-09-28	Semi-Annually	0.00%
7872.T	Ex Dividend Junior	2024-03-28	Annually	0.00%
7013.T	No Dividend Player	2023-09-28	Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0726	1.500	8.55	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0424	1.200	8.59	10.00	[0 - 0.3]
returnOnEquityTTM	0.0639	1.500	-0.402	-0.602	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	2.29	0.800	3.53	2.82	[1 - 3]
quickRatioTTM	1.083	0.800	8.33	6.67	[0.8 - 2.5]
cashRatioTTM	0.202	1.500	9.99	10.00	[0.2 - 2]
debtRatioTTM	0.0944	-1.500	8.43	-10.00	[0 - 0.6]
interestCoverageTTM	182.83	1.000	10.00	10.00	[3 - 30]
operatingCashFlowPerShareTTM	346.01	2.00	10.00	10.00	[0 - 30]
freeCashFlowPerShareTTM	346.01	2.00	10.00	10.00	[0 - 20]
debtEquityRatioTTM	0.141	-1.500	9.44	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.214	1.000	9.77	9.77	[0.2 - 0.8]
operatingProfitMarginTTM	0.0930	1.000	-0.139	-0.139	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.744	1.000	6.98	6.98	[0.2 - 2]
assetTurnoverTTM	0.584	0.800	9.44	7.55	[0.5 - 2]
Total Score				11.20

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	12.06	1.000	8.88	0	[1 - 100]
returnOnEquityTTM	0.0639	2.50	-0.258	-0.602	[0.1 - 1.5]
freeCashFlowPerShareTTM	346.01	2.00	10.00	10.00	[0 - 30]
dividendYielPercentageTTM	2.27	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	346.01	2.00	10.00	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	-0.476	1.500	-6.51	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.120	1.000	9.50	0	[0.1 - 0.5]
Total Score				3.80

Daito Pharmaceutical

Daito Pharmaceutical Co.,Ltd. manufactures and sells pharmaceutical products worldwide. The company offers various active pharmaceutical ingredients and intermediates, prescription drugs, OTC drugs, and home-delivery medicines; formulations in various forms, such as tablets, capsules, troches, granules, and powders; and contract manufacturing services for formulations of medicinal products to pharmaceutical companies. It also sells health food products. The company was formerly known as Daito Corporation and changed its name to Daito Pharmaceutical Co.,Ltd. in 1992. Daito Pharmaceutical Co.,Ltd. was incorporated in 1942 and is headquartered in Toyama, Japan.